- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Top-selling biotech drugs based on revenue 2017
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Top-selling biotech drugs based on revenue 2017
Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)
by Matej Mikulic,
last edited
Aug 8, 2019
This statistic shows a ranking of the top 10 best-selling biotech drugs worldwide in 2017. In that year, Enbrel generated a revenue of some 7.9 billion U.S. dollars for co-marketing companies Amgen, Pfizer, Takeda (Japan), and Wyeth (rest of world), and thus was the world's third biotech drug based on revenue.
Best-selling biotech drugs worldwide
AbbVie’s Humira and Roche's Rituxan are among the top selling biotechnology drugs in the world, generating 18.4 billion U.S. dollars and 9.2 billion U.S. dollars, respectively, in 2017. Biotechnology has become more prevalent within the pharmaceutical industry. One of the first uses of biotechnology was for human insulin. The United States had around 860 dedicated biotechnology companies in 2015. However, one of the largest biotechnology companies in the world is headquartered in Basel, Switzerland. Roche generated some 34 billion U.S. dollars in biotech prescription drug revenues in 2017 and is expected to reach 42 billion U.S. dollars in 2024. One of their top selling drugs, Avastin, generated about 7.1 billion U.S. dollars in revenue in 2017. Avastin is a drug derived from biotechnology that is used to inhibit the growth of new blood vessels to treat some types of cancer.
The United States spent about 28.6 billion U.S. dollars on research and development in the biotechnology sector. The United States has also had about 34 percent of the world’s share of filed biotechnology patents in 2014, in comparison, Germany filed eight percent of global biotech patents.
Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)
| Trade name (Manufacturer) | Revenue in billion U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Trade name (Manufacturer) | Revenue in billion U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Aug 8, 2019
This statistic shows a ranking of the top 10 best-selling biotech drugs worldwide in 2017. In that year, Enbrel generated a revenue of some 7.9 billion U.S. dollars for co-marketing companies Amgen, Pfizer, Takeda (Japan), and Wyeth (rest of world), and thus was the world's third biotech drug based on revenue.
Best-selling biotech drugs worldwide
AbbVie’s Humira and Roche's Rituxan are among the top selling biotechnology drugs in the world, generating 18.4 billion U.S. dollars and 9.2 billion U.S. dollars, respectively, in 2017. Biotechnology has become more prevalent within the pharmaceutical industry. One of the first uses of biotechnology was for human insulin. The United States had around 860 dedicated biotechnology companies in 2015. However, one of the largest biotechnology companies in the world is headquartered in Basel, Switzerland. Roche generated some 34 billion U.S. dollars in biotech prescription drug revenues in 2017 and is expected to reach 42 billion U.S. dollars in 2024. One of their top selling drugs, Avastin, generated about 7.1 billion U.S. dollars in revenue in 2017. Avastin is a drug derived from biotechnology that is used to inhibit the growth of new blood vessels to treat some types of cancer.
The United States spent about 28.6 billion U.S. dollars on research and development in the biotechnology sector. The United States has also had about 34 percent of the world’s share of filed biotechnology patents in 2014, in comparison, Germany filed eight percent of global biotech patents.
- Show sources information
- Show publisher information
- Release date
- February 2019
- Region
- Worldwide
- Survey time period
- 2017
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- February 2019
More information
- Region
- Worldwide
- Survey time period
- 2017
- Open this statistic in...
Other statistics on the topic
Biotechnology industry
+Farming
Percentage of genetically modified crops in the U.S. by type 1997, 2018 & 2019
+Pharmaceutical Products & Market
Gross profit margin of select U.S. biotech and drugs companies Q2 2019
+Pharmaceutical Products & Market
Top global biotech companies based on market capitalization 2018
+Pharmaceutical Products & Market
Amgen's top product revenues 2016-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Pharmaceutical brands: Humira (AbbVie)
- 38 page/s
- English
- pptx
- Detailed references
Everything On "Pharmaceutical brands: Humira (AbbVie)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Biotech industry"
- Global overview
The most important statistics
- Global top 10 companies based on biotech prescription drug revenue in 2018 and 2024 (in billion U.S. dollars)*Global top companies based on biotech prescription drug revenue in 2018 and 2024
- Top global biotechnology companies based on market capitalization as of 2018 (in billion U.S. dollars)Top global biotech companies based on market capitalization 2018
- Select top global biotechnology companies' R&D expenditure in 2017 (in million U.S. dollars)Top global biotech companies - R&D expenditure 2017
- Selected top biotechnology companies based on number of employees worldwide in 2017Top global biotech companies based on number of employees 2017
- Value of the NASDAQ biotech Index from 2010 to 2017NASDAQ biotech index closing values 2010-2017
- Change in pharmaceutical and biotech industry stock indices worldwide in 2018Change in global biotech-pharma industry stock indices 2018
- U.S. companies
The most important statistics
- Gilead Sciences' revenue from 2006 to 2018 (in million U.S. dollars)Gilead Sciences' revenue 2006-2018
- Top products of Gilead Sciences from 2016 to 2018, based on revenue (in million U.S. dollars)Gilead Sciences' top products based on revenue 2016-2018
- Total revenue of biotech company Amgen from 2004 to 2018 (in million U.S. dollars)Amgen's total revenue 2004-2018
- Revenues of selected Amgen's top products from 2016 to 2018 (in million U.S. dollars)Amgen's top product revenues 2016-2018
- Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)Biogen's revenue and net income 2007-2018
- Biogen's top products from 2016 to 2018, based on revenue (in million U.S. dollars)Biogen's top products based on revenue 2016-2018
- Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016Market cap CAGR of biotech companies in the U.S. 2012-2016
- Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*Pre-commercial biotech companies with large market caps in the U.S. 2017
- Research & development
The most important statistics
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018
- Average cost to bring a pharmaceutical asset to market among large cap biopharma companies between 2010 and 2018 (in billion U.S. dollars)Cost to bring large cap biopharmaceutical assets to market 2010-2018
- Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018 (in billion U.S. dollars)Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2018
- Projected rate of return on biopharmaceutical research and development investments from 2010 to 2018Projected return on biopharma R&D investments U.S. 2010-2018
- Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (in million U.S. dollars)Alliances in U.S. and Europe biotechnology industry with big up-front payments 2016
- Products
The most important statistics
- Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)Global biologics spending 2002-2017
- Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)Top-selling biotech drugs based on revenue 2017
- Number of biopharma medicines in development in the U.S. as of April 2019, by therapeutic category*Pharmaceuticals: biopharma medicines in development in 2019, by category
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Total U.S. pharmaceutical and biotech revenues for products 5 years after launch from 2007 to 2017 (in billion U.S. dollars)Total U.S. pharma and biotech product sales 5 years after launch 2007-2017
- Funding/investment
The most important statistics
- Total biotechnology funding by the National Institutes for Health (NIH) from FY 2013 to FY 2020 (in million U.S. dollars)biotechnology funding by National Institutes for Health 2013-2020
- Bioscience venture capital investments in the U.S. between 2014 and 2017, by sector (in million U.S. dollars)U.S. bioscience venture capital investments by segment 2014-2017
- Biotech/pharmaceutical investments in the legal cannabis industry in the United States from 2015 to 2017 (in million U.S. dollars)*Legal cannabis industry investments on biotech in the U.S. 2015-2017
- Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)Value of U.S. and EU biotech IPOs, January-October 2017
- Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars)Amount of top U.S. biotech venture financings 2017
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*Capital raised by regenerative medicine companies worldwide 2016-2018
- Biotech in agriculture
The most important statistics
- Acreage of genetically modified crops worldwide from 2003 to 2018 (in million hectares)Acreage of genetically modified crops worldwide 2003-2018
- Acreage of genetically modified crops worldwide from 2015 to 2018, by leading country (in million hectares)*Acreage of genetically modified crops 2015-2018, by country
- Percentage of genetically modified crops in the U.S. in 1997, 2018 and 2019, by type (as percent of total acreage)Percentage of genetically modified crops in the U.S. by type 1997, 2018 & 2019
- Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*Monsanto's seed and genomics segment net sales 2011-2017
- Sales of Syngenta AG worldwide from 2013 to 2018, by segment (in billion U.S. dollars)Syngenta AG's sales worldwide by segment 2013-2018
- Bayer CropScience's revenue from 2005 to 2018 (in million euros)Bayer CropScience's revenue 2005-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Italy: number of biotech drugs marketed 2016-2017, by type
- Italy: number of patients treated with biological medicaments 2018, by disease
- Insulin-replacement medications - revenues 2010
- Biotech drugs - revenues
- Italy: turnover of biotech drugs 2014-2017
- Italy: value of investments in R&D of biotech pharma companies 2014-2017
- Italy: number of R&D employees of biotech pharma companies 2014-2017
- U.S. bioscience employment distribution 2016 by subsector
- U.S. bioscience employment totals 2016
- Latin America: chromatography instrumentation revenue 2018-2023
- Italy: number of biotech projects along the drug pipeline 2016-2017, by area
- Number of U.S. bioscience establishments by subsectors 2016
- Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
- U.S. metropolitan areas by employment in research and medical laboratories 2016
- U.S. bioscience employment by subsector 2016
- Argentina: pharma exports 2016-2017, by type of medicine
- Number of biotechnology patents in Estonia 2005-2016
- Research, experimental development on biotechnology revenue in Luxembourg 2010-2022
- Number of biotechnology patents in Hungary 2005-2016
- Industry revenue of »research, experimental development on biotechnology« in Austria 2011-...
Statistics on "Biotech industry"
- Global top companies based on biotech prescription drug revenue in 2018 and 2024
- Top global biotech companies based on market capitalization 2018
- Top global biotech companies - R&D expenditure 2017
- Top global biotech companies based on number of employees 2017
- NASDAQ biotech index closing values 2010-2017
- Change in global biotech-pharma industry stock indices 2018
- Gilead Sciences' revenue 2006-2018
- Gilead Sciences' top products based on revenue 2016-2018
- Amgen's total revenue 2004-2018
- Amgen's top product revenues 2016-2018
- Biogen's revenue and net income 2007-2018
- Biogen's top products based on revenue 2016-2018
- Market cap CAGR of biotech companies in the U.S. 2012-2016
- Pre-commercial biotech companies with large market caps in the U.S. 2017
- Gross profit margin of select U.S. biotech and drugs companies Q2 2019
- Expected top life science startups in the U.S. 2019
- Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018
- Cost to bring large cap biopharmaceutical assets to market 2010-2018
- Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2018
- Projected return on biopharma R&D investments U.S. 2010-2018
- Alliances in U.S. and Europe biotechnology industry with big up-front payments 2016
- Global biologics spending 2002-2017
- Top-selling biotech drugs based on revenue 2017
- Pharmaceuticals: biopharma medicines in development in 2019, by category
- U.S. biopharmaceutical export volume 2002-2017
- Projection of top 2018 pharma and biotech launches by revenue 2022
- Total U.S. pharma and biotech product sales 5 years after launch 2007-2017
- biotechnology funding by National Institutes for Health 2013-2020
- U.S. bioscience venture capital investments by segment 2014-2017
- Legal cannabis industry investments on biotech in the U.S. 2015-2017
- Value of U.S. and EU biotech IPOs, January-October 2017
- Amount of top U.S. biotech venture financings 2017
- Capital raised by regenerative medicine companies worldwide 2016-2018
- Acreage of genetically modified crops worldwide 2003-2018
- Acreage of genetically modified crops 2015-2018, by country
- Percentage of genetically modified crops in the U.S. by type 1997, 2018 & 2019
- Monsanto's seed and genomics segment net sales 2011-2017
- Syngenta AG's sales worldwide by segment 2013-2018
- Bayer CropScience's revenue 2005-2018
- Italy: number of biotech drugs marketed 2016-2017, by type
- Italy: number of patients treated with biological medicaments 2018, by disease
- Insulin-replacement medications - revenues 2010
- Biotech drugs - revenues
- Italy: turnover of biotech drugs 2014-2017
- Italy: value of investments in R&D of biotech pharma companies 2014-2017
- Italy: number of R&D employees of biotech pharma companies 2014-2017
- U.S. bioscience employment distribution 2016 by subsector
- U.S. bioscience employment totals 2016
- Latin America: chromatography instrumentation revenue 2018-2023
- Italy: number of biotech projects along the drug pipeline 2016-2017, by area
- Number of U.S. bioscience establishments by subsectors 2016
- Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
- U.S. metropolitan areas by employment in research and medical laboratories 2016
- U.S. bioscience employment by subsector 2016
- Argentina: pharma exports 2016-2017, by type of medicine
- Number of biotechnology patents in Estonia 2005-2016
- Research, experimental development on biotechnology revenue in Luxembourg 2010-2022
- Number of biotechnology patents in Hungary 2005-2016
- Industry revenue of »research, experimental development on biotechnology« in Austria 2011-2023
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.